Abbott laboratories (ABT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Sep'08Jun'08
Net sales

32,095

31,904

31,355

30,935

30,723

30,578

30,402

29,575

28,445

27,390

25,134

23,607

22,303

20,853

20,708

20,556

20,393

20,405

20,573

20,502

20,389

20,247

18,899

18,645

19,034

19,657

18,837

19,277

19,144

19,050

8,794

13,346

17,649

21,407

38,441

37,299

36,509

35,166

33,989

33,075

31,744

30,764

29,472

29,024

0

0

0

Cost of products sold, excluding amortization of intangible assets

13,352

13,231

12,988

12,796

12,799

12,706

12,797

12,507

12,414

12,409

11,509

10,918

10,016

9,094

8,918

8,875

8,806

8,747

8,878

8,955

9,025

9,218

8,842

8,778

9,035

9,193

8,912

9,146

8,971

8,899

5,532

7,016

8,517

10,017

15,747

15,515

15,189

14,665

14,404

14,023

13,608

13,209

12,777

12,537

0

0

0

Amortization of intangible assets

2,011

1,936

1,941

2,001

2,080

2,178

2,250

2,207

2,037

1,975

1,536

1,175

928

550

572

583

589

601

621

602

584

555

438

452

516

588

537

586

584

595

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

2,346

2,440

2,407

2,385

2,383

2,300

2,357

2,351

2,296

2,260

2,009

1,793

1,621

1,447

1,448

1,474

1,471

1,405

1,397

1,324

1,289

1,345

1,307

1,341

1,394

1,371

1,424

1,435

1,443

1,461

-380

278

945

1,512

4,035

4,104

3,924

3,724

3,414

3,010

2,823

2,743

2,677

2,658

0

0

0

Acquired in-process and collaborations research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

347

0

0

-

-

0

-

-

-

-

-

-

0

Selling, general and administrative

9,835

9,765

9,711

9,648

9,680

9,744

9,862

9,600

9,284

9,182

8,378

7,891

7,478

6,736

6,718

6,756

6,746

6,785

6,796

6,725

6,647

6,530

6,124

6,141

6,206

6,372

6,271

6,579

6,678

6,735

3,089

5,408

6,356

7,365

12,648

11,082

11,064

10,376

9,804

9,216

8,497

8,405

8,248

8,215

0

0

0

Total operating cost and expenses

27,544

27,372

27,047

26,830

26,942

26,928

27,266

26,665

26,031

25,826

23,432

21,777

20,043

17,827

17,656

17,688

17,612

17,538

17,692

17,606

17,545

17,648

16,711

16,712

17,151

17,524

17,145

17,748

17,678

17,690

9,452

13,719

16,812

19,778

32,942

31,213

30,590

29,079

27,867

26,495

25,099

24,528

23,703

23,489

0

0

0

Operating earnings

4,551

4,532

4,308

4,105

3,781

3,650

3,136

2,910

2,414

1,564

1,702

1,830

2,260

3,026

3,052

2,868

2,781

2,867

2,881

2,896

2,844

2,599

2,188

1,933

1,883

2,133

1,691

1,528

1,465

1,360

-657

-372

837

1,629

5,499

6,085

5,918

6,087

6,121

6,580

6,645

6,235

5,768

5,535

0

0

0

Interest expense

638

670

692

728

770

826

886

901

905

904

811

710

599

431

319

243

184

163

165

159

151

150

134

136

140

145

120

235

278

320

272

244

295

359

555

580

580

553

525

511

513

519

520

523

0

0

0

Interest (income)

89

94

103

101

100

105

106

120

130

124

113

99

88

99

107

110

117

105

97

90

82

77

72

70

68

67

7

55

57

59

102

59

59

65

83

78

97

105

112

135

131

137

163

179

0

0

0

(Income) from the TAP Pharmaceutical Products Inc. joint venture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net foreign exchange (gain) loss

-6

-7

-35

-39

-37

-28

-2

15

21

34

36

21

-1

-495

-467

-444

-439

93

87

74

79

24

-8

-7

-18

-46

-28

-18

16

31

-6

-13

-27

20

67

83

113

10

-14

-35

-91

-35

-45

-60

0

0

0

Debt extinguishment costs

-

-

-

-

-

-167

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other (income) expense, net

145

191

186

113

153

139

227

278

280

1,413

1,492

487

399

-786

-1,005

-30

257

281

275

275

-6

-14

1

25

35

32

-7

-37

-39

1

48

56

56

-119

-82

-91

-89

62

74

406

411

1,375

1,378

1,361

0

0

0

Earnings from continuing operations before taxes

4,078

4,077

3,784

3,399

3,074

2,873

2,500

2,408

1,926

2,231

2,532

1,727

2,147

1,413

1,368

2,261

2,532

3,183

3,157

3,158

2,830

2,518

2,119

1,885

1,828

2,041

191

-57

-129

-220

-784

-514

630

1,236

5,012

5,575

5,459

5,712

5,767

6,575

6,583

7,193

6,743

6,508

0

0

0

Tax expense (benefit) on earnings from continuing operations

519

390

491

514

477

539

1,685

1,584

1,550

1,878

550

663

754

350

375

315

399

577

612

771

804

797

708

268

160

53

-608

-552

-559

-457

98

404

17

110

462

437

972

1,086

1,043

1,261

1,273

1,447

1,452

1,375

0

0

0

Earnings from continuing operations

3,559

3,687

3,293

2,885

2,597

2,334

815

824

376

353

1,982

1,064

1,393

1,063

993

1,946

2,133

2,606

2,545

2,387

2,026

1,721

1,411

1,617

1,668

1,988

800

494

429

237

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings from discontinued operations, net of tax

0

-

-

-

-

34

77

79

0

-

0

0

-

337

376

332

314

1,817

1,845

1,902

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings from Discontinued Operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

110

321

256

0

0

-

0

-

-

563

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings (loss) from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of Discontinued Operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

16

16

32

31

1,752

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Earnings

3,579

3,687

3,292

2,895

2,622

2,368

886

926

476

477

2,103

1,171

1,503

1,400

1,369

2,278

2,447

4,423

4,561

4,519

4,201

2,284

1,969

2,397

2,407

2,576

3,039

4,016

5,264

5,963

6,527

4,888

5,106

4,728

4,550

5,138

4,486

4,626

4,724

5,313

5,310

5,745

5,291

5,133

0

0

0

Basic Earnings Per Common Share
Continuing operations (in dollars per share)

0.31

0.58

0.54

0.57

0.38

0.37

0.31

0.41

0.23

-0.49

0.32

0.15

0.22

0.51

-0.24

0.40

0.04

0.46

0.40

0.52

0.35

0.42

0.29

0.28

0.14

0.21

0.41

0.30

0.35

-0.54

0.21

0.26

0.22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

0.01

-

-

-

-

-0.01

0.01

0.01

0.01

0.02

0.02

0.01

0.02

0.03

0.02

0.01

0.17

0.05

-0.01

0.00

1.17

0.17

0.07

0.03

0.10

-

0.21

-

-

1.20

1.01

0.83

0.57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net earnings (in dollars per share)

0.32

0.58

0.54

0.57

0.38

0.36

0.32

0.42

0.24

-0.47

0.34

0.16

0.24

0.54

-0.22

0.41

0.21

0.51

0.39

0.52

1.52

0.59

0.36

0.31

0.24

0.37

0.62

0.30

0.35

0.66

1.22

1.09

0.79

1.04

0.19

1.24

0.56

0.92

0.58

0.83

0.65

1.00

0.95

0.83

0.93

0.70

0.86

Diluted Earnings Per Common Share
Continuing operations (in dollars per share)

0.30

0.59

0.53

0.56

0.38

0.37

0.31

0.40

0.23

-0.49

0.32

0.15

0.22

0.51

-0.24

0.40

0.04

0.46

0.39

0.52

0.35

0.41

0.29

0.28

0.14

0.21

0.41

0.30

0.34

-0.54

0.21

0.26

0.22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

0.01

-

-

-

-

-

0.01

0.01

-

0.02

0.02

0.01

0.02

0.03

0.02

0.01

0.17

0.05

-0.01

0.00

1.16

0.18

0.07

0.02

0.10

-

0.20

-

-

1.19

1.00

0.82

0.56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net earnings (in dollars per share)

0.31

0.59

0.53

0.56

0.38

0.37

0.32

0.41

0.23

-0.47

0.34

0.16

0.24

0.54

-0.22

0.41

0.21

0.51

0.38

0.52

1.51

0.59

0.36

0.30

0.24

0.37

0.61

0.30

0.34

0.65

1.21

1.08

0.78

1.04

0.19

1.23

0.55

0.92

0.57

0.83

0.64

0.99

0.95

0.83

0.92

0.69

0.85

Cash Dividends Declared Per Common Share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

0.26

0.26

0.26

-

0.26

0.26

0.26

-

0.24

0.24

0.24

-

0.22

0.22

0.22

-

0.14

0.14

0.14

-

0.51

0.51

0.51

-

0.48

0.48

0.48

-

0.44

0.44

0.44

-

0.40

0.40

0.40

0.36

0.36

Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares)

1,768

1,768

1,771

1,768

1,763

1,761

1,759

1,757

1,753

1,748

1,743

1,740

1,727

1,479

1,476

1,474

1,477

1,489

1,495

1,493

1,504

1,515

1,508

1,506

1,532

1,550

1,551

1,560

1,568

1,577

1,576

1,572

1,573

1,560

1,558

1,556

1,551

1,547

1,545

1,544

1,547

1,550

1,546

1,545

1,545

1,545

1,539

Dilutive Common Stock Options (in shares)

11

13

12

12

13

12

12

11

11

9

10

8

7

5

6

5

6

9

9

10

10

7

11

10

14

15

14

16

17

18

17

16

15

14

9

9

6

8

8

7

13

10

6

4

10

18

13

Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares)

1,780

1,781

1,784

1,781

1,776

1,774

1,771

1,768

1,765

1,757

1,754

1,748

1,735

1,491

1,476

1,480

1,483

1,499

1,505

1,504

1,515

1,523

1,519

1,517

1,547

1,566

1,566

1,576

1,586

1,595

1,594

1,588

1,589

1,574

1,568

1,566

1,558

1,556

1,554

1,551

1,561

1,561

1,552

1,550

1,556

1,563

1,553

Outstanding Common Stock Options Having No Dilutive Effect (in shares)

4

239

0

0

4

-

0

0

-

-

0

5

9

-3

12

5

5

-2

0

0

5

-1

0

0

4

-4

1

1

5

-1

1

1

3

-77

61

60

63

-44

66

66

29

23

83

90

67

3

48